Idraparinux and liver enzymes: observations from the PERSIST trial.
Markus Reiter(Vienna General Hospital), Erich Minar(Medical University of Vienna), Nihat Koca(Vienna General Hospital), Jürgen Heger(Vienna General Hospital), Robert A. Bucek(Medical University of Vienna)
Cited by 18
Related Papers
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
|New England Journal of Medicine|2006|1.2k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length
|Circulation|2007|515
Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting
|Circulation|2007|500
The Risk of Recurrent Venous Thromboembolism in Men and Women
|New England Journal of Medicine|2004|478